Human Reproduction, Vol. 17, No. 10, 2535-2539,
October 2002
© 2002 European Society of Human Reproduction and Embryology
Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women
1 Nuffield Department of Obstetrics and Gynaecology, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, 2 Department of Obstetrics and Gynaecology, Haroldwood Hospital, Essex RM3 0BE and 3 School of Biological and Molecular Sciences, Oxford Brookes University, Headington, Oxford, UK
BACKGROUND: The objective of this study was to confirm the source and study the acute changes and relationship between inhibins and FSH at surgical menopause. METHODS: Regularly cycling women (42–47 years; n = 10) undergoing bilateral oophorectomy for non-ovarian pathology were recruited for this study. One blood sample was taken before surgery and after removal of the ovaries, samples were taken every 15 min up to 1 h, hourly up to 6 h, after 12 h and daily during the hospital admission (3 days). RESULTS: There were five women in the follicular phase and five women in the luteal phase of the cycle. For women in both phases, levels of inhibin A, inhibin B, estradiol (E2) and progesterone decreased after the removal of the ovaries. Serum FSH levels started to rise after 12 h in both follicular and luteal phase women after the surgical menopause. Correlation analysis showed that inhibin A and E2 were significantly negatively correlated in both phases with FSH concentration. Inhibin B had a negative correlation in the follicular phase and progesterone had a negative correlation in the luteal phase. CONCLUSIONS: This study showed that ovarian inhibin A and B were cleared from the circulation within 12 h of oophorectomy, whereas E2 and progesterone remain in the circulation for longer. Negative correlation between FSH, inhibin A and inhibin B suggests that inhibins may contribute to the observed early rise in FSH after the surgical menopause.
Key words: FSH/inhibin/menopause/estradiol/progesterone
4 Present address: Department of Obstetrics and Gynaecology, RFUCL Medical School, 86–96 Chenies Mews, London WC1E 6HX
5 Present address: Section of Reproductive and Developmental Medicine, Jessop Wing, Tree root walk, Sheffield
6 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Royal Free–University College London Medical School, 86–96 Chenies Mews, London WC1E 6HX, UK. E-mail: s.muttukrishna{at}ucl.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kok, K. M. van Asselt, Y. T. van der Schouw, I. van der Tweel, P. H.M. Peeters, P. W.F. Wilson, P. L. Pearson, and D. E. Grobbee Heart Disease Risk Determines Menopausal Age Rather Than the Reverse J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1976 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Luisi, P. Florio, F. M. Reis, and F. Petraglia Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy Hum. Reprod. Update, March 1, 2005; 11(2): 123 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hestiantoro and D. F. Swaab Changes in Estrogen Receptor-{alpha} and -{beta} in the Infundibular Nucleus of the Human Hypothalamus Are Related to the Occurrence of Alzheimer's Disease Neuropathology J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1912 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Halmesmaki, R. Hurskainen, A. Tiitinen, J. Teperi, S. Grenman, A. Kivela, E. Kujansuu, M. Yliskoski, and J. Paavonen A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia--effect on FSH levels and menopausal symptoms Hum. Reprod., February 1, 2004; 19(2): 378 - 382. [Abstract] [Full Text] [PDF]
|
|